Partnering opportunity

Highly potent ligands of the ghrelin receptor to influence food intake

Summary

A German University has developed synthesized short peptides that show high inverse agonist potency towards the ghrelin receptor, which is useful in the treatment of feeding-related disorders, such as obesity. The endogenous ligand ghrelin is the only known orexigenic gastrointestinal peptide and plays a central role in the regulation of appetite and energy homeostasis. The university is looking for partners from industry for further R&D and license agreements.

Partner sought

The university is looking for partners from industry for further research and development in order to improve therapies against food disorders and to pursue the implementation of a product development and for license agreements to focus the market launch.

Description

The research institute of a German University was found in 2003 and promotes the networking of research within the university while simultaneously utilizing emerging interdisciplinary synergies. A research group of the institute developed synthesized short peptides that show high inverse agonist potency towards the ghrelin receptor, which is useful in the treatment of feeding-related disorders, such as obesity. The endogenous ligand ghrelin is the only known orexigenic gastrointestinal peptide, which plays a central role in the regulation of appetite and energy homeostasis. The ghrelin receptor is a G protein-coupled receptor (GPCR) mainly expressed in the brain, but also in other tissues such as stomach, liver and heart. The receptor possesses a high constitutive activity. It was suggested to induce constant appetite and to trigger food intake in between meals. Its endogenous ligand ghrelin is the only known orexigenic gastrointestinal peptide and plays a central role in the regulation of appetite and energy homeostasis. Reducing the basal activity of the ghrelin receptor could be an innovative strategy to develop anti-obesity drugs. Although obesity is a worldwide steadily increasing problem so far there are only few pharmaceuticals available, most presenting moderate benefits, poor tolerance and strong side effects. Therefore developing highly potent inverse agonists for the ghrelin receptor may be useful in the treatment of feeding-related disorders. The group was able to synthesize short peptides that show high inverse agonist potency toward the ghrelin receptor. Potential fields of application are appetite or eating disorders, obesity and obesity-associated disorders, metabolic and/or endocrine disorders, addictive disorders, chronic liver disease and cardiovascular disorders. The university is looking for partners from industry for further R&D to pursue the implementation of a product development and for license agreement, respectively, to focus the market launch.

Advantages and innovations

The peptides are capable of increasing or decreasing the constitutive activity of ghrelin receptor by at least 10%. Based on these peptides drugs for a multitude of diseases, obesity e.g.,could be developed

Development stage

Under development/lab tested

Intellectual Property Rights (IPR)

Secret Know-how


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company